3649.T Stock - FINDEX Inc.
Unlock GoAI Insights for 3649.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.84B | $5.19B | $4.54B | $4.97B | $4.00B |
| Gross Profit | $3.55B | $3.33B | $2.72B | $2.56B | $2.12B |
| Gross Margin | 60.8% | 64.1% | 60.0% | 51.5% | 52.9% |
| Operating Income | $1.53B | $1.50B | $1.03B | $920.72M | $636.28M |
| Net Income | $1.16B | $1.06B | $722.78M | $636.03M | $430.46M |
| Net Margin | 19.9% | 20.4% | 15.9% | 12.8% | 10.7% |
| EPS | $45.30 | $41.31 | $28.21 | $24.84 | $16.81 |
FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
3649.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $6.80 | — | — |
Q2 2025 | May 14, 2025 | — | $22.53 | — | — |
Q1 2025 | Feb 11, 2025 | — | $12.89 | — | — |
Q4 2024 | Nov 13, 2024 | — | $5.08 | — | — |
Q3 2024 | Aug 13, 2024 | — | $2.28 | — | — |
Q2 2024 | May 14, 2024 | — | $25.07 | — | — |
Q1 2024 | Feb 13, 2024 | — | $19.18 | — | — |
Q4 2023 | Nov 13, 2023 | — | $11.05 | — | — |
Q3 2023 | Aug 9, 2023 | — | $3.30 | — | — |
Q2 2023 | May 11, 2023 | — | $7.78 | — | — |
Q1 2023 | Feb 13, 2023 | — | $14.56 | — | — |
Q4 2022 | Nov 10, 2022 | — | $1.16 | — | — |
Q3 2022 | Aug 9, 2022 | — | $2.39 | — | — |
Q2 2022 | May 12, 2022 | — | $10.10 | — | — |
Q1 2022 | Feb 9, 2022 | — | $5.89 | — | — |
Q4 2021 | Nov 11, 2021 | — | $5.65 | — | — |
Q3 2021 | Aug 12, 2021 | — | $1.02 | — | — |
Q2 2021 | May 13, 2021 | — | $12.28 | — | — |
Q1 2021 | Feb 10, 2021 | — | $3.43 | — | — |
Q4 2020 | Nov 12, 2020 | — | $-1.28 | — | — |
Latest News
Frequently Asked Questions about 3649.T
What is 3649.T's current stock price?
What is the analyst price target for 3649.T?
What sector is FINDEX Inc. in?
What is 3649.T's market cap?
Does 3649.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 3649.T for comparison